Mycronic AB (publ)
STO:MYCR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
266.5472
447.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mycronic AB (publ)
Mycronic AB (publ)
Income from Continuing Operations
Mycronic AB (publ)
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mycronic AB (publ)
STO:MYCR
|
Income from Continuing Operations
kr1.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
38%
|
|
|
S
|
Smart Eye AB (publ)
STO:SEYE
|
Income from Continuing Operations
-kr36m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pricer AB
STO:PRIC B
|
Income from Continuing Operations
-kr48.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hexagon AB
STO:HEXA B
|
Income from Continuing Operations
€871.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lagercrantz Group AB
STO:LAGR B
|
Income from Continuing Operations
kr877m
|
CAGR 3-Years
31%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Ependion AB
STO:EPEN
|
Income from Continuing Operations
kr156.3m
|
CAGR 3-Years
126%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Mycronic AB (publ)
Glance View
Nestled in the heart of Sweden’s tech industry, Mycronic AB (publ) stands as a beacon of innovation in the realm of advanced production equipment for the electronics market. Founded in 1989, the company has carved a strong foothold with its cutting-edge technology that supports the manufacturing of electronic assemblies and advanced semiconductors. At the core of Mycronic's success is its prowess in the development and production of precision equipment that facilitates the manufacturing process in the electronics industry. Their offerings include mask writers for display manufacturing and surface mount technology (SMT) equipment that optimize and refine the production of circuit boards. These technologies play a crucial role in the production of everything from smartphones to sophisticated defense systems, making Mycronic an indispensable player in its sector. Mycronic’s business model hinges on the delivery of these high-value, technologically advanced manufacturing solutions that enable their clients to enhance productivity and maintain a competitive edge. What sets Mycronic apart is their ability to leverage decades of expertise to continuously innovate and offer bespoke solutions tailored to the shifting demands of electronic manufacturers worldwide. The company profits not only from the sale of its equipment but also from a dedicated stream of recurring revenue originating from software updates, technical support, and maintenance services. This dual revenue model allows Mycronic to build long-lasting relationships with its clients, nurturing a business that is as much about technological excellence as it is about sustainable growth and adaptation in an ever-evolving global market.
See Also
What is Mycronic AB (publ)'s Income from Continuing Operations?
Income from Continuing Operations
1.7B
SEK
Based on the financial report for Sep 30, 2024, Mycronic AB (publ)'s Income from Continuing Operations amounts to 1.7B SEK.
What is Mycronic AB (publ)'s Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
38%
Over the last year, the Income from Continuing Operations growth was 136%. The average annual Income from Continuing Operations growth rates for Mycronic AB (publ) have been 28% over the past three years , 16% over the past five years , and 38% over the past ten years .
You don't have any saved screeners yet
